Immunitybio, Inc.
Clinical trials sponsored by Immunitybio, Inc., explained in plain language.
-
New bladder cancer treatment aims to avoid surgery
Disease control Not yet recruitingThis study is testing two different drug combinations, delivered directly into the bladder, to treat a specific type of bladder cancer. The goal is to see if these treatments can effectively control the cancer without needing surgery. The trial will enroll about 20 adults with in…
Phase: PHASE2 • Sponsor: ImmunityBio, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New hope for lymphoma patients: trial tests Chemo-Free drug combo
Disease control Not yet recruitingThis study is testing a new combination of immunotherapy drugs for adults with a slow-growing type of B-cell non-Hodgkin lymphoma that has come back or hasn't responded to previous treatments. The goal is to see if this chemotherapy-free approach can control the cancer. About 20 …
Phase: PHASE2 • Sponsor: ImmunityBio, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Experimental drug trial seeks to tame long COVID's lingering misery
Disease control Not yet recruitingThis study aims to test the safety and side effects of an experimental drug called Anktiva in people with Long COVID. Twenty adults with persistent symptoms like fatigue, brain fog, and shortness of breath for at least 60 days will receive up to two doses. Researchers will closel…
Phase: PHASE2 • Sponsor: ImmunityBio, Inc. • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC